Complete androgen blockage in the treatment of metastatic prostate cancer
Matzkin, H.; Braf, Z.
Harefuah 126(5): 260-263
1994
ISSN/ISBN: 0017-7768 PMID: 8188104 Document Number: 438684
Document emailed within 1 workday
Related Documents
Neri, B.; Bartalucci, S.; Pieri, A.; Gemelli, M.T.; Rizzo, M.; Bartoletti, R.; Trippitelli, A.; Paoletti, M.C. 1989: Complete androgen blockade as treatment for advanced prostate cancer: clinical response and side-effects Anticancer Research 9(1): 13-16Gómez Veiga, F.; Lorenzo Patiño, M.J.; Díaz Bermúdez, J.; Duarte Novo, J.; Alvarez Castelo, L.; Chantada Abal, V.; Sánchez Rodríguez, J.; González Martín, M. 1997: Effect of complete androgen block before radical prostatectomy for cancer of the prostate Archivos Espanoles de Urologia 50(4): 355-363
2013: Metastatic prostate cancer progressing despite androgen suppression: two main options Prescrire International 22(136): 77
Pettaway, C.A. 1999: Racial differences in the androgen/androgen receptor pathway in prostate cancer Journal of the National Medical Association 91(12): 653-660
Izbicka, E.; MacDonald, J.R.; Davidson, K.; Lawrence, R.A.; Gomez, L.; Von Hoff, D.D. 1999: 5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells Anticancer Research 19(2a): 1285-1291
Bastos, D.A.; Dzik, C.; Rathkopf, D.; Scher, H.I. 2014: Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer Oncology 28(8): 693-699
Koivisto, P.; Kononen, J.; Palmberg, C.; Tammela, T.; Hyytinen, E.; Isola, J.; Trapman, J.; Cleutjens, K.; Noordzij, A.; Visakorpi, T.; Kallioniemi, O.P. 1997: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer Cancer Research 57(2): 314-319
Kirby, R.S. 1996: Maximal androgen blockade (MAB) for the treatment of prostate cancer British Journal of Clinical Practice 50(5): 287
Amler, L.C.; Agus, D.B.; LeDuc, C.; Sapinoso, M.L.; Fox, W.D.; Kern, S.; Lee, D.; Wang, V.; Leysens, M.; Higgins, B.; Martin, J.; Gerald, W.; Dracopoli, N.; Cordon-Cardo, C.; Scher, H.I.; Hampton, G.M. 2000: Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1 Cancer Research 60(21): 6134-6141
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Guan, X-xiang.; Chen, L-bang. 2006: Current opinions on the treatment of androgen-independent prostate cancer Zhonghua Nan Ke Xue 12(11): 1021-1025
Fitzpatrick, J.M. 1996: Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: the argument against European Urology 29(Suppl): 37-39
Gao, J.; Isaacs, J.T. 1998: Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells Cancer Research 58(15): 3299-3306
Jarrard, D.F.; Kinoshita, H.; Shi, Y.; Sandefur, C.; Hoff, D.; Meisner, L.F.; Chang, C.; Herman, J.G.; Isaacs, W.B.; Nassif, N. 1998: Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells Cancer Research 58(23): 5310-5314
Labrie, F.; Dupont, A.; Bélanger, A.; Lacourcière, Y.; Monfette, J.E.; Monfette, G. 1986: Combined anti-androgen treatment in adenocarcinoma of the prostate: first use of a new therapeutically efficacious principle in hormone-dependent cancer Annales d'Urologie 20(2): 98-106
Eiken, P.A.; Langdahl, B.L.; Eiken, F.L.; Walter, S.; Poulsen, M.Hvid.; Abrahamsen, B. 2011: Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer Ugeskrift for Laeger 173(48): 3093-3096
Ecstein-Fraisse, E.; Su, Z. 2014: Cabazitaxel--a next-generation taxane for the treatment of patients with metastatic castration-resistant prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(7): 817-822
Leewansangtong, S.; Soontrapa, S. 2003: The pattern of prostate-specific antigen responses following hormonal therapy in Thai men with bone metastatic prostate cancer Journal of the Medical Association of Thailand 86(9): 809-815
Kagebayashi, Y.; Ozono, S.; Takashima, K.; Yoshikawa, M.; Hayashi, Y.; Kaneko, Y.; Maruyama, Y.; Hirao, Y.; Okajima, E. 1997: Total androgen blockade for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 43(3): 197-201
Roth, B.J. 1999: Androgen-independent prostate cancer: not so chemorefractory after all Seminars in Oncology 26(6 Suppl 18: 43-50